Report #2835504

Received Apr 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: AL
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
TDAP	TDAP (BOOSTRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	9YB4G	—

Symptoms (1)

Product storage error

Symptom narrative

Boostrix stored at 33.8F for 16hrs 45 mins/ Boostrix used in patients since excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in an unspecified number of patients who received DTPa (Reduced antigen) (Boostrix) (batch number 9YB4G, expiry date 20-NOV-2026) for prophylaxis. On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced incorrect storage of drug (Verbatim: Boostrix stored at 33.8F for 16hrs 45 mins/ Boostrix used in patients since excursion). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 28-MAR-2025 The HCP (health care professional) requested stability data for Havrix, Kinrix, Pediarix, Boostrix, Infanrix, Engerix-B stored at 33.8F for 16 hours and 45 mins. No prior excursions and Boostrix used in patients since excursion, which led to an incorrect storage of drug.